Gough Tamara J, Wise Terry G, Bruce Matthew P, Doran Timothy J, Layton Daniel S, Bean Andrew G D
Health and Biosecurity, Australian Centre for Disease Preparedness, Commonwealth Scientific and Industrial Research Organisation, Geelong, VIC 3220, Australia.
Animals (Basel). 2025 Jun 24;15(13):1868. doi: 10.3390/ani15131868.
The creation of transgenic chickens holds significant promise for the agricultural and biotechnological sectors, offering potential improvements in disease resistance and production efficiency. The preferred method for generating gene-edited chickens involves the genetic manipulation of primordial germ cells (PGCs), making the identification and isolation of these cells a growing focus of research. PGCs are the precursors to sperm and oocytes, responsible for transmitting genetic material to the next generation. In humans, PGCs are characterized by their large size, round nuclei, and refractive lipids in the cytoplasm, and can be identified using periodic acid-Schiff (PAS) staining and the surface marker stage-specific embryonic antigen 1 (SSEA1). Similarly, chicken PGCs express SSEA1, but their most specific marker is the chicken vasa homologue (CVH), the avian equivalent of the RNA-binding factor gene . However, SSEA1, along with other known surface markers, does not bind to all PGCs or lacks specificity, while CVH, although highly specific to PGCs, is intracellular and unsuitable for isolating viable cells. This study aims to develop an antibody targeting a PGC surface marker with the same specificity as CVH. Despite the importance of identifying surface markers for PGC characterization, to date, such reagents are limited. To address this, whole chicken PGCs were injected into mice, leading to the generation of a panel of monoclonal antibodies. One antibody was found to bind cultured chicken PGCs and showed reduced expression upon differentiation with retinoic acid, indicating its specificity to PGCs. Immunoprecipitation followed by mass spectrometry identified the antigen as myosin heavy chain-like (MYH9) protein. The antibody, αMYH9, was further characterized and shown to bind circulating PGCs and embryonic gonadal PGCs (Hamburger Hamilton (H-H) stage 30, embryonic day 6.5-7). Whilst our primary aim was to determine the binding to PGCs, further investigation is required to determine potential binding to somatic cells. In conclusion, this study provides the characterization of a surface marker for chicken PGCs, with significant implications for advancements in avian genetic preservation, agriculture, and biotechnology.
转基因鸡的培育对农业和生物技术领域具有重大前景,有望在抗病性和生产效率方面取得潜在改进。生成基因编辑鸡的首选方法涉及对原始生殖细胞(PGCs)进行基因操作,因此这些细胞的识别和分离成为日益受到关注的研究重点。PGCs是精子和卵母细胞的前体,负责将遗传物质传递给下一代。在人类中,PGCs的特征是体积大、细胞核圆形且细胞质中有折光性脂质,可通过过碘酸希夫(PAS)染色和表面标志物阶段特异性胚胎抗原1(SSEA1)进行识别。同样,鸡PGCs表达SSEA1,但其最特异的标志物是鸡vasa同源物(CVH),即RNA结合因子基因的鸟类对应物。然而,SSEA1以及其他已知的表面标志物不能与所有PGCs结合或缺乏特异性,而CVH虽然对PGCs具有高度特异性,但它是细胞内的,不适合用于分离活细胞。本研究旨在开发一种针对PGC表面标志物的抗体,其特异性与CVH相同。尽管识别用于PGC表征的表面标志物很重要,但迄今为止,此类试剂有限。为了解决这个问题,将完整的鸡PGCs注射到小鼠体内,从而产生了一组单克隆抗体。发现一种抗体可与培养的鸡PGCs结合,并在视黄酸诱导分化后表达降低,表明其对PGCs具有特异性。免疫沉淀后进行质谱分析确定该抗原为肌球蛋白重链样(MYH9)蛋白。对该抗体αMYH9进行了进一步表征,结果表明它可与循环中的PGCs以及胚胎性腺PGCs(汉伯格-汉密尔顿(H-H)第30阶段,胚胎第6.5 - 7天)结合。虽然我们的主要目的是确定其与PGCs的结合情况,但还需要进一步研究来确定其与体细胞的潜在结合情况。总之,本研究对鸡PGCs的一种表面标志物进行了表征,这对鸟类遗传保存、农业和生物技术的进展具有重要意义。